4.7 Review

Probiotic engineering strategies for the heterologous production of antimicrobial peptides

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 176, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2021.113863

Keywords

Probiotics; Synthetic biology; Bioengineering; Genetic circuits; Antimicrobial peptides; Living medicines

Funding

  1. AIChE Foundation - Institute for Diabetes, Obesity, and Metabolism
  2. Penn Mental Health AIDS Research Center of the University of Pennsylvania
  3. Perelman School of Medicine at the University of Pennsylvania
  4. National Institute of General Medical Sciences of the National Institutes of Health [R35GM138201]
  5. Defense Threat Reduction Agency (DTRA) [HDTRA11810041, HDTRA1-21-1-0014]
  6. U.S. Department of Defense (DOD) [HDTRA11810041] Funding Source: U.S. Department of Defense (DOD)

Ask authors/readers for more resources

The article discusses the innovative approach of engineering probiotic bacteria for treating and detecting diseases, including the potential of antimicrobial peptides in combating antibiotic-resistant infections. Delivering AMPs to the gut via engineered probiotics can treat drug-resistant pathogens and reshape the microbiota in real-time.
Engineered probiotic bacteria represent an innovative approach for treating and detecting a wide range of diseases including those caused by infectious agents. Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics for combating antibiotic-resistant infections. These molecules can be delivered orally to the gut by using engineered probiotics, which confer protection against AMP degradation, thus enabling numerous applications including treating drug-resistant enteric pathogens and remodeling the microbiota in real time. Here, we provide an update on the current state of the art on AMP-producing probiotics, discuss methods to enhance gut colonization, and end by outlining future perspectives. (c) 2021 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Chemistry, Multidisciplinary

Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery

Marcelo D. T. Torres, Jicong Cao, Octavio L. Franco, Timothy K. Lu, Cesar de la Fuente-Nunez

Summary: Antibiotic resistance poses a significant global health challenge, with the need for innovative strategies becoming more urgent. Antimicrobial peptides (AMPs) offer a natural template for the discovery, design, and production of antibiotics, potentially leading the way for future advancements in peptide drug discovery through computational and synthetic biology approaches.

ACS NANO (2021)

Review Immunology

Molecular Dynamics for Antimicrobial Peptide Discovery

Nicholas Palmer, Jacqueline R. M. A. Maasch, Marcelo D. T. Torres, Cesar de la Fuente-Nunez

Summary: Antimicrobial resistance is a growing concern, with only two new classes of antibiotics approved for human use since the 1960s. Molecular dynamics simulation is a valuable tool for understanding antibiotic mechanisms and can lay the groundwork for new antibiotic discovery. Antimicrobial peptides show promise in combating resistance due to their lower tendency to induce resistance compared to small-molecule antibiotics.

INFECTION AND IMMUNITY (2021)

Article Biochemistry & Molecular Biology

Hydrogel-based biocontainment of bacteria for continuous sensing and computation

Tzu-Chieh Tang, Eleonore Tham, Xinyue Liu, Kevin Yehl, Alexis J. Rovner, Hyunwoo Yuk, Cesar de la Fuente-Nunez, Farren J. Isaacs, Xuanhe Zhao, Timothy K. Lu

Summary: A hydrogel-based encapsulation system, known as DEPCOS, has been developed to provide deployable physical containment for genetically modified microorganisms, preventing their escape and protecting them against environmental insults. It also allows for controlled lifespan and easy retrieval of bacteria, showcasing versatility in executing useful functions such as cell-cell communication and heavy metal sensing.

NATURE CHEMICAL BIOLOGY (2021)

Article Chemistry, Multidisciplinary

Synthetic Antibiotic Derived from Sequences Encrypted in a Protein from Human Plasma

Angela Cesaro, Marcelo D. T. Torres, Rosa Gaglione, Eliana Dell'Olmo, Rocco Di Girolamo, Andrea Bosso, Elio Pizzo, Henk P. Haagsman, Edwin J. A. Veldhuizen, Cesar de la Fuente-Nunez, Angela Arciello

Summary: Encrypted peptides in the human proteome have been found to have potent antimicrobial activity against drug-resistant bacteria, without causing bacterial resistance. Blood may serve as an important source of antimicrobials.

ACS NANO (2022)

Article Engineering, Biomedical

Mining for encrypted peptide antibiotics in the human proteome

Marcelo D. T. Torres, Marcelo C. R. Melo, Orlando Crescenzi, Eugenio Notomista, Cesar de la Fuente-Nunez

Summary: By mining the human proteome, researchers identified 2,603 encrypted peptide antibiotics with antibacterial activity and low bacterial resistance, which target pathogenic bacteria by modulating their membranes and demonstrate anti-infective properties in mouse infection models. Additionally, peptides from the same geographical region show synergistic antimicrobial effects.

NATURE BIOMEDICAL ENGINEERING (2022)

Article Chemistry, Multidisciplinary

Autonomous Treatment of Bacterial Infections in Vivo Using Antimicrobial Micro- and Nanomotors

Xavier Arque, Marcelo D. T. Torres, Tania Patino, Andreia Boaro, Samuel Sanchez, Cesar de la Fuente-Nunez

Summary: The increasing resistance of bacteria to antibiotics is a major global public health threat. Current antibiotic treatments are hindered by poor delivery to the infection site, leading to off-target effects and drug resistance. This study presents micro- and nanomotors that autonomously deliver antibiotics to specific areas, showing effective bactericidal activity against Gram-positive and Gram-negative bacteria in vitro by rapidly depolarizing their membrane. This technology provides a much-needed tool to direct therapeutics to infection sites and combat drug-resistant infections.

ACS NANO (2022)

Editorial Material Respiratory System

Antimicrobial Peptides: Potential Therapeutics Against Drug-Resistant Pulmonary Infections

Lucia Ageitos, Cesar de la Fuente-Nunez

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Editorial Material Biotechnology & Applied Microbiology

Antibiotic discovery with machine learning

Cesar de la Fuente-Nunez

Summary: This study utilizes artificial intelligence to find candidate peptide antibiotics in the human gut microbiome.

NATURE BIOTECHNOLOGY (2022)

Article Multidisciplinary Sciences

Detection of SARS-CoV-2 with RAPID: A prospective cohort study

Marcelo D. T. Torres, Lucas F. de Lima, Andre L. Ferreira, William R. de Araujo, Paul Callahan, Antonio Davila, Benjamin S. Abella, Cesar de la Fuente-Nunez

Summary: This study presents a rapid, accurate, inexpensive, and scalable test for diagnosing COVID-19 at the point-of-care. The method showed high sensitivity, specificity, and accuracy in the testing.

ISCIENCE (2022)

Article Public, Environmental & Occupational Health

Identification of the first COVID-19 infections in the US using a retrospective analysis (REMEDID)

David Garcia-Garcia, Enrique Morales, Cesar De La Fuente-Nunez, Isabel Vigo, Eva S. Fonfria, Cesar Bordehore

Summary: Accurate detection of early COVID-19 cases is crucial to reduce infections and deaths. This study used seroprevalence data and a new methodology to analyze the initial spread of SARS-CoV-2 infections in the US. Results showed that the virus likely entered the country on December 28, 2019, and on average a month earlier than previously recorded.

SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY (2022)

Correction Engineering, Biomedical

Mining for encrypted peptide antibiotics in the human proteome (vol 29, pg 1235, 2021)

Marcelo D. T. Torres, Marcelo C. R. Melo, Laurice Flowers, Orlando Crescenzi, Eugenio Notomista, Cesar de la Fuente-Nunez

NATURE BIOMEDICAL ENGINEERING (2022)

Editorial Material Engineering, Biomedical

Mining for antimicrobial peptides in sequence space

Fangping Wan, Cesar de la Fuente-Nunez

Summary: A machine-learning pipeline is used to identify effective antimicrobial peptides by progressively narrowing down the search space of polypeptide chain sequences.

NATURE BIOMEDICAL ENGINEERING (2023)

News Item Biochemistry & Molecular Biology

Antibiotic identified by AI

Angela Cesaro, Cesar de la Fuente-Nunez

NATURE CHEMICAL BIOLOGY (2023)

Review Multidisciplinary Sciences

Leveraging artificial intelligence in the fight against infectious diseases

Felix Wong, Cesar de la Fuente-nunez, James J. Collins

Summary: Despite advancements in various fields, infectious diseases still pose a significant threat to public health. Combating pathogen outbreaks, pandemics, and antimicrobial resistance requires interdisciplinary efforts. With the integration of systems and synthetic biology, artificial intelligence (AI) has emerged as a valuable tool in anti-infective drug discovery, understanding infection biology, and accelerating diagnostics. This review explores the current progress supported by AI and discusses potential future applications in controlling infectious disease outbreaks and pandemics.

SCIENCE (2023)

No Data Available